Biogen, Inc. (BIIB)
177.21
+1.37
(+0.78%)
USD |
NASDAQ |
Dec 10, 15:09
Biogen Price: 177.21 for Dec. 10, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 316.84 |
| Eli Lilly & Co. | 997.70 |
| Merck & Co., Inc. | 97.83 |
| Pfizer Inc. | 25.76 |
| Stoke Therapeutics, Inc. | 34.15 |
Price Related Metrics
| PE Ratio | 16.16 |
| PS Ratio | 2.682 |
| Price to Book Value | 1.428 |
| Price to Free Cash Flow | 11.49 |
| Earnings Yield | 6.19% |
| Market Cap | 26.00B |
| Operating PE Ratio | 10.65 |
| Normalized PE Ratio | 14.33 |